Clinical evaluation of glutaraldehyde with calcium hydroxide and glutaraldehyde with zinc oxide eugenol in pulpotomy of primary molars

Dental Traumatology

Volumn 15, Issue 6, 1999, Pages 259-264

  Shumayrikh, N M ^a   Adenubi, J O ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Glutaraldehyde; Primary molars; Pulpotomy

Indexed keywords

CALCIUM HYDROXIDE; GLUTARALDEHYDE; ZINC OXIDE EUGENOL;

ARTICLE; CHI SQUARE DISTRIBUTION; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECIDUOUS TOOTH; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; ENDODONTICS; FEMALE; FOLLOW UP; HUMAN; MALE; METHODOLOGY; MOLAR TOOTH; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; TREATMENT OUTCOME;

CALCIUM HYDROXIDE; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; DENTAL PULP CAPPING; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; FOLLOW-UP STUDIES; GLUTARAL; HUMANS; MALE; MOLAR; PULPOTOMY; REPRODUCIBILITY OF RESULTS; TOOTH, DECIDUOUS; TREATMENT OUTCOME; ZINC OXIDE-EUGENOL CEMENT;

EID: 0033291685     PISSN: 16004469     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-9657.1999.tb00784.x     Document Type: Article

References (52)

1. Buckley JP. The chemistry of pulp decomposition with a rational treatment for this condition and its sequelae. J Am Dent Assoc 1904;90:280-8.
2. Sweet CA. Procedure for treatment of exposed and pulpless deciduous teeth. J Am Dent Assoc 1930;17:1150-3.
3. Law DB, Lewis TM. Formocresol pulpotomy in deciduous teeth. J Am Dent Assoc 1964;69:601-7.
4. Morawa AP, Straffon LH, Han SS, Corpron RE. Clinical evaluation of pulpotomies using dilute formocresol. J Dent Child 1975;42:360-3.
5. Magnusson BO. Therapeutic pulpotomies in primary molars with the formocresol technique. A clinical and histological follow-up. Acta Odontol Scand 1978;36:157-65.
6. Loos PJ, Straffon LH, Han SS. Biological effects of formocresol. J Dent Child 1973;40:193-7.
7. Block RM, Lewis RD, Hirsch J, Coffey J, Langeland K. Systemic distribution of 14C-labelled paraformaldehyde incorporated within formocresol following pulpotomies of dogs. J Endod 1983;9:176-89.
8. Ranly DM, Horn D. Assessment of the systemic distribution and toxicity of formaldehyde following pulpotomy treatment. Part one. J Dent Child 1985;52:431-4.
9. Ranly DM, Horn D. Assessment of the systemic distribution and toxicity of formaldehyde following pulpotomy treatment. Part two. J Dent Child 1987;54:40-4.
10. Pruhs RJ, Olen GA, Sharma PS. Relationship between formocresol pulpotomies on primary teeth and enamel defects on their permanent successors. J Am Dent Assoc 1877;94:698-700.
11. Block RM, Lewis RD, Hirsch J, Coffey J, Langeland K. Systemic distribution of 14C-labeled paraformaldehyde incorporated within formocresol pulpotomies in dogs. J Endod 1983;9:176-89.
12. Pashley EL, Myers DR, Pashley DH, Whitford GM. Systematic distribution of 14C-formaldehyde from formocresol treated pulpotomy sites. J Dent Res 1980;59:603-8.
13. Myers DR, Pashley DH, Whitford GM, McKinney RV. Tissue changes induced by the absorption of formocresol from pulpotomy sites in dogs. Pediatr Dent 1983;5:6-8.
14. Turner JG. Two cases of hypoplasia of enamel. Br J Dent Sci 1912;55:227-8.
15. Alacam A. Long-term effects of primary teeth pulpotomies with formocresol, glutaraldehyde-calcium HYdroxide and glutaraldehyde-zinc oxide-eugenol on succedaneous teeth. J Pedodont 1989;13:307-12.
16. Garcia-Godoy F. Radiographic evaluation of root canal calcification following formocresol pulpotomy. J Dent Child 1983;50:430-2.
17. Boeve C, Dermaut L. Formocresol pulpotomy in primary molars. A long-term radiographic evaluation. J Dent Child 1982;50:191-4.
18. Val Velzen TT, Feltkamp-Vroom M. Immunologic consequences of formaldehyde fixation in autologous tissue implants. J Endod 1977;3:179-85.
19. Block RM, Lewis RD, Sheaths JB, Burke SG. Anti-body formation to dog pulp tissue altered by formocresol within the root canal. Oral Surg 1978;45:282-92.
20. Griesemer RA. Report of the Federal Panel on Formaldehyde. Nov 1980. p. 3.
21. Lewis BB, Chestner SB. Formaldehyde in dentistry: a review of mutagenic and carcinogenic potential. J Am Dent Assoc 1981;103:429-34.
22. Wemes JC, s'Gravenmade EJ. Glutaraldehyde: a new fixative in endodontics. J Dent Res 1973 52:601 (abstr. no. 48).
23. Russell AD. The biological uses and importance of glutaraldehyde. Prog Med Chem 1976;13:271-301.
24. Dankert J, s'Gravenmade EJ, Wemes JC. Diffusion of formocresol and glutaraldehyde through dentine and cementum. J Endod 1976;2:42-6.
25. Kopel HM, Bernick S, Zachrisson E, De Romero SA. The effects of glutaraldehyde on primary pulp tissue following coronal amputation: an in vivo histologic study. J Dent Child 1980;47:425-30.
26. Davis MJ, Myers R, Switkes MD. Glutaraldehyde: an alternative to formocresol for vital pulp therapy. J Dent Child 1982; 49:176-80.
27. Fuks AB, Bimstein E, Klein H. Assessment of a 2% buffered glutaraldehyde solution in pulpotomized primary teeth of school children. A preliminary report. J Pedodont 1986;10:3 23-30.
28. Prakash C, Chandra S, Jaiswal JN. Formocresol and glutaraldehyde pulpotomies in primary teeth. J Pedod 1989;13:314-22.
29. Ranly DM. The effect of pH and concentration on the glutaraldehyde fixation of bovine pulp. An in vitro study. Acta Odontol Pediatr 1983;4:45-7.
30. Jeng HW, Feigal RJ, Messer HH. Comparison of the cytotoxicity of formocresol, formaldehyde, cresol, and glutaraldehyde using human pulp fibroblast cultures. Pediatr Dent 1987;9:295-300.
31. Lekka M, Hume WR, Wolinsky LE. Comparison between formaldehyde and glutaraldehyde diffusion through the root tissues of pulpotomy-treated teeth. J Pedodont 1984;8:185-91.
32. Garcia-Godoy F. A 42 month clinical evaluation of glutaraldehyde pulpotomies in primary teeth. J Pedod 1986;10:148-55.
33. Ranly DM, Horn D, Hubbard GB. Assessment of the systemic distribution and toxicity of glutaraldehyde as a pulpotomy agent. Pediatr Dent 1989;11:8-13.
34. Garcia-Godoy F, Ranly DM. Clinical evaluation of pulpotomies with ZOE as the vehicle for glutaraldehyde. Pediatr Dent 1987;9:144-6.
35. Tsai TP, Su HL, Tseng LH. Glutaraldehyde preparations and pulpotomy in primary molars. Oral Surg Oral Med Oral Pathol 1993;76:346-50.
36. Fuks AB, BImstein E, Guelmann M, Klein H. Assessment of a 2 percent buffered glutaraldehyde solution in pulpotomized primary teeth of school children. J Dent Child 1990;57:371-5.
37. Bimstein E, Shoshan S. Enhanced healing of tooth pulp wounds in the dog by enriched collagen solution as a capping agent. Arch Oral Biol 1981;26:97-101.
38. Bouvier M, Joffre A, Magloire H. In vitro mineralization of a three-dimensional collagen matrix by human dental pulp cells in the presence of chondroitin sulphate. Arch Oral Biol 1990;35:301-9.
39. Schroder U. A 2-year follow-up of primary molars, pulpotomized with a gentle technique and capped with calcium hydroxide. Scand J Dent Res 1978;86:273-8.
40. Heilig J, Yates J, Siskin M, McKnight J, Turner J. Calcium hydroxide pulpotomy for primary teeth: a clinical study. J Am Dent Assoc 1984;108:775-8.
41. Mack RB, Dean JA. Electrosurgical pulpotomy: a retrospective human study. ASDC J Dent Child 1993; 60: 107-14.
42. Oztas N, Ulusu T, Oygur T, Cokpekin F. Comparison of electrosurgery and formocresol as pulpotomy techniques in dog primary teeth. J Clin Pediatr Dent 1994;18:285-9.
43. Kurumadea F. A study on the application of Ga-As semiconductor laser to endodontics. The effects of laser irradiation on the activation of inflammatory cells and the vital pulpotomy [in Japanese, English abstract]. Ohu Daigaku Shigkushi 1990;17:233-44.
44. Frentzen M, Koort HJ, Thiensir I. Excimer lasers in dentistry: future possibilities with advanced technology. Quintessence Int 1992;23:117-33.
45. Fei A, Udin RD, Johnson R. A clinical study of ferric sulfate as a pulpotomy agent in primary teeth. Pediatr Dent 1991; 13:327-32.
46. Fuks AB, Jholan G, Davis JM, Eidelman E. Ferric sulfate versus diluted formocresol in pulpotomized primary molars: long-term follow-up. Pediatr Dent 1997;19:327-30.
47. Rutherford RB, Spangberg L, Tucker M, Rueger D, Charette M. The time-course of the induction of reparative dentine formation in monkeys by recombinant human osteogenic protein-1. Arch Oral Biol 1994;39:833-8.
48. Nakashima M. Induction of dentine in amputated pulp of dogs by recombinant human bone morphogenetic proteins-2 and 4 with collagen matrix. Arch Oral Biol 1994;39:1085-9.
49. Cook SD, Rueger DC. Osteogenic protein-1: biology and applications. Clin Orthop 1996;324:29-38.
50. Rolling I, Lambjerg-Hansen H. Pulp condition of successfully formocresol-treated primary molars. Scand J Dent Res 1978; 86:267-72.
51. Koch G, Nyborg H. Correlation between clinical and histological indications for pulpotomy for deciduous teeth. J Int Assoc Dent Child 1970;1:1-10.
52. Garcia-Godoy F. Clinical evaluation of glutaraldehyde pulpotomies in primary teeth. Acta Odontol Pediatr 1983;4:41-4.